Dalit Landesman‐Milo

Author

Tel Aviv University

Also Known As

Dalit Landesman-Milo, Dalit Landesman‐Milo

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Tel Aviv University Massachusetts Institute of Technology

About

Dalit Landesman‐Milo is an author at Tel Aviv University specializing in medicine, engineering, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	735
2	Engineering	5	5	676
3	Biomedical Engineering	3	3	601
4	Health Sciences	1	1	83
5	Biochemistry	1	1	13

Dalit Landesman‐Milo

Publications

954

Citations

H-Index

Page 1

	Year	Citations
Nanoparticle Hydrophobicity Dictates Immune Response Daniel F. Moyano, Meir Goldsmith, David J. Solfiell, Journal of the American Chemical Society NanoparticlesNanomedicineCross-protectionEngineeringNanobiotechnology	2012	472
Correction of Hyperglycemia in Diabetic Mice Transplanted with Reversibly Immortalized Pancreatic β Cells Controlled by the tet-on Regulatory System Dalit Landesman‐Milo, Manju Surana, Irina Berkovich, Cell Transplantation T-regulatory CellImmunologyDiabetic Mice TransplantedBeta Cell LinesCell Proliferation	2001	83
Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells Dalit Landesman‐Milo, Meir Goldsmith, Shani Leviatan Ben‐Arye, Cancer Letters NanoparticlesEngineeringTherapeutic NanomaterialsNano-drug DeliveryBiomedical Engineering	2012	65
Quaternized starch-based carrier for siRNA delivery: From cellular uptake to gene silencing Eliz Amar‐Lewis, Aharon Azagury, Ramesh Chintakunta, Journal of Controlled Release Cell-based Drug DeliveryEngineeringStarch-based CarrierCellular UptakeBiotechnology	2014	64
Toxicity profiling of several common RNAi-based nanomedicines: a comparative study Dalit Landesman‐Milo, Dan Peer Drug Delivery and Translational Research NanoparticlesNanomedicineEngineeringToxicity ProfilingNanobiotechnology	2013	62
Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer Manu Smriti Singh, Srinivas Ramishetti, Dalit Landesman‐Milo, Small	2021	62
eIF3c: A potential therapeutic target for cancer Rafi Emmanuel, Shiri Weinstein, Dalit Landesman‐Milo, Cancer Letters Potential Therapeutic TargetTumor BiologyMedicineCancer TreatmentCancer Biology	2013	41
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles Shoshy Mizrahy, Inbal Hazan‐Halevy, Dalit Landesman‐Milo, Frontiers in Immunology	2017	40
An ovarian spheroid based tumor model that represents vascularized tumors and enables the investigation of nanomedicine therapeutics Manu Smriti Singh, Meir Goldsmith, Kavita Thakur, Nanoscale	2019	27
A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway Zohar Tiran, Anat Oren, Chen Hermesh, Clinical Cancer Research	2008	25

Page 1